Use of floxuridine to modulate the antiviral activity of zidovudine

AIDS Research and Human Retroviruses

Volumn 12, Issue 11, 1996, Pages 965-968

  Medina, Daniel J ^a   Tung, Peter P ^b   Sathya, Bhavani ^a   Strair, Roger K ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; NEVIRAPINE; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

EID: 0029757711     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.965     Document Type: Review

References (8)

1. Wei X, Ghosh SK, Taylor MV, Johnson VA, Emini EA, Deutsh P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Nature (London) 1995;373:117.
2. Loveday C, Kaye S, Tenant-Flowers M, Semple M, Ayliffe U, Weller ID, and Tedder RS: Lancet 1995;345:820-825.
3. Ho DD, Neumann AU, Chen W, Leonard JM, and Markowitz M: Nature (London) 1995;373:123-126.
4. Havlir D, Easterman S, and Richman DD: HIV-1 kinetics: Rates of production and clearance of viral populations in asymptomatic patients treated with nevirapine. 2nd Natl. Conf. on Human Retroviruses and Related Infections. Washington, DC; Jan. 1995. Abstract 229.
5. Richman D, Shih CK, Lowy I, Rose J, Prodanavich P, Goff S, and Griffin J: Proc Natl Acad Sci USA 1991;88:11241-11251.
6. Mellors J, Dutschman G, Im G, Tramontano E, Winkler SR, and Cheng YC: Mol Pharmacol 1992;41:446-451.
7. Strair RK, Medina DJ, Nelson CJ, Graubert T, and Mellors JW: Nucleic Acids Res 1993;21:4836-4842.
8. Medina DJ, Tung PP, Lerner-Tung MB, Nelson CJ, Mellors JW, and Strair RK: J Virol 1995;69:1606-1611.